Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153905 | SCV000203518 | benign | not specified | 2014-03-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001513084 | SCV001720619 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001513084 | SCV001897044 | benign | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807102 | SCV002054541 | benign | Developmental and epileptic encephalopathy, 62 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807101 | SCV002054542 | benign | Epilepsy, familial focal, with variable foci 4 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000153905 | SCV005087806 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 35% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 33. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001513084 | SCV005239568 | benign | not provided | criteria provided, single submitter | not provided |